미국 · 보도자료 · Bright Minds Biosciences · 2026-09-30 21:30
브라이트 마인즈, 2026 FPWR 연구 심포지엄 및 PWS 콘퍼런스 참가
NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“ Bright Minds ” or the “ Company ”), a clinical stage biotechnology company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, Prader-Willi Syndrome, depression, and other central nervous system (CNS) disorders, today announced that it will partic
Bright Minds Biosciences 다른 공시·급등 이유 보기 · GK의 공시레이더 — 미국·한국 실시간 공시
